Trust Co. of Vermont raised its position in shares of Xylem Inc (NYSE:XYL) by 56.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,526 shares of the industrial products company’s stock after purchasing an additional 2,363 shares during the period. Trust Co. of Vermont’s holdings in Xylem were worth $516,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Cullen Frost Bankers Inc. purchased a new position in shares of Xylem in the first quarter worth approximately $28,000. Liberty Wealth Management LLC purchased a new position in shares of Xylem in the fourth quarter worth approximately $35,000. Doyle Wealth Management purchased a new position in shares of Xylem in the fourth quarter worth approximately $36,000. CWM LLC increased its position in shares of Xylem by 100.9% in the fourth quarter. CWM LLC now owns 681 shares of the industrial products company’s stock worth $45,000 after acquiring an additional 342 shares in the last quarter. Finally, Meeder Asset Management Inc. increased its position in shares of Xylem by 5,057.1% in the fourth quarter. Meeder Asset Management Inc. now owns 722 shares of the industrial products company’s stock worth $48,000 after acquiring an additional 708 shares in the last quarter. 85.45% of the stock is owned by hedge funds and other institutional investors.
Shares of XYL traded down $0.27 during trading hours on Wednesday, hitting $73.97. The stock had a trading volume of 952,869 shares, compared to its average volume of 948,705. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.02 and a current ratio of 1.44. Xylem Inc has a 52 week low of $60.65 and a 52 week high of $84.41. The firm has a market cap of $13.35 billion, a price-to-earnings ratio of 25.68, a PEG ratio of 1.39 and a beta of 1.15.
Xylem (NYSE:XYL) last posted its earnings results on Thursday, May 2nd. The industrial products company reported $0.52 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). Xylem had a return on equity of 19.46% and a net margin of 10.50%. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.25 billion. During the same period in the previous year, the company posted $0.51 EPS. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Xylem Inc will post 3.23 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 1.30%. The ex-dividend date is Wednesday, May 29th. Xylem’s payout ratio is 33.33%.
In other Xylem news, SVP Pak Steven Leung sold 8,947 shares of the stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $78.55, for a total transaction of $702,786.85. Following the sale, the senior vice president now owns 42,980 shares of the company’s stock, valued at approximately $3,376,079. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Claudia S. Toussaint sold 2,344 shares of the company’s stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $80.08, for a total transaction of $187,707.52. Following the transaction, the senior vice president now owns 48,449 shares in the company, valued at $3,879,795.92. The disclosure for this sale can be found here. In the last ninety days, insiders sold 65,280 shares of company stock worth $5,165,009. 0.85% of the stock is owned by insiders.
A number of brokerages recently commented on XYL. ValuEngine downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research report on Tuesday, May 14th. Cowen downgraded shares of Xylem from an “outperform” rating to a “market perform” rating and lowered their price objective for the company from $75.00 to $72.00 in a research report on Tuesday, May 14th. Stifel Nicolaus decreased their target price on shares of Xylem from $93.00 to $89.00 and set a “buy” rating for the company in a research report on Friday, May 3rd. Janney Montgomery Scott raised shares of Xylem from a “neutral” rating to a “buy” rating and set a $86.00 target price for the company in a research report on Friday, May 3rd. Finally, Zacks Investment Research raised shares of Xylem from a “sell” rating to a “hold” rating in a research report on Saturday, April 13th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $78.93.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Read More: Recession
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.